Interference of S100A16 suppresses lipid accumulation and inflammation in high glucose-induced HK-2 cells
Authors:
- 3 January 2021
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 53 (6) , 1-9
Abstract
Purpose Diabetic nephropathy (DN) is a major complication of diabetic mellitus and usually leads to the end-stage renal disease. Inflammation-induced lipid disorders have been proposed to play an important role in the pathogenesis of DN. S100A16 is a novel adipogenic factor, but has not been investigated in DN. This study aims to explore the role of S100A16 in high glucose (HG)-induced HK-2 cells. Methods CCK-8 assay was used to detect cell viability. Cell transfection was performed to knockdown S100A16. Oil red staining was performed to assay lipid accumulation. qRT-PCR and western blotting were conducted to examine corresponding gene expression. Intracellular cholesterol was determined by enzymatic assay. Inflammatory cytokines production was measured using ELISA kits. Results The results exhibited lipid accumulation and upregulation of S100A16 in HG-induced HK-2 cells. S100A16 knockdown significantly reduced lipid droplets and cholesterol, and decreased the production of inflammatory cytokines induced by HG. Besides, S100A16 knockdown decreased the expression of SCAP, SREBP1, SCD1 and SCAP. However, the inhibitory effect in HG-induced HK-2 cells made by S100A16 was reversed by SREBP1 overexpression. Conclusion These results suggested that S100A16 knockdown might protect against HG-induced lipid accumulation and inflammation in HK-2 cells through regulating SCAP/SREBP1 signaling.Keywords
This publication has 32 references indexed in Scilit:
- Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 PathwayInternational Journal of Endocrinology, 2013
- An Essential Requirement for the SCAP/SREBP Signaling Axis to Protect Cancer Cells from LipotoxicityCancer Research, 2013
- Effect of RAS inhibition on TGF-β, renal function and structure in experimentally induced diabetic hypertensive nephropathy ratsBiomedicine & Pharmacotherapy, 2013
- Microarray analysis of the inflammatory and immune responses in head kidney turbot leucocytes treated with resveratrolInternational Immunopharmacology, 2013
- Reduction of renal lipid content and proteinuria by a PPAR-γ agonist in a rat model of angiotensin II-induced hypertensionEuropean Journal of Pharmacology, 2012
- The Scap/SREBP Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in AnimalsCell Metabolism, 2012
- Pathogenesis of diabetic nephropathyJournal of Diabetes Investigation, 2011
- Identification of S100A16 as a Novel Adipogenesis Promoting Factor in 3T3-L1 CellsEndocrinology, 2011
- The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuriaAmerican Journal of Physiology-Renal Physiology, 2009
- SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysisCell, 1994